SEC Form 3 · accession 0001567619-19-002164
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dave Helsel
Officer — SVP Global Operations and R&D
Period of report
Jan 23, 2019
Accepted (ET)
Feb 1, 2019 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 14,090 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $17.20 | holding | — | — | — | — | Dec 18, 2027 | Common Stock | 50,000 | — | D |
| Non-Qualified Stock Option (right to buy)F3 | $20.93 | holding | — | — | — | — | Jul 18, 2028 | Common Stock | 15,663 | — | D |
| Performance RightF4 | $0.00 | holding | — | — | — | — | — | Common Stock | 10,000 | — | D |
| Performance RightF5 | $0.00 | holding | — | — | — | — | — | Common Stock | 9,834 | — | D |
Explanation of responses
- F1This number includes (i) 7,500 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") underlying restricted stock units, of which 2,500 shares will vest on each of December 18, 2019, 2020 and 2021, and (ii) 4,916 shares of Common Stock of the Company underlying restricted stock units, of which 1,228 shares will vest on each of July 18, 2019 and 2020, and 1,230 shares will vest on each of July 18, 2021 and 2022.
- F2These stock options vest in four annual installments beginning on December 18, 2018, such that 12,500 options vested on December 18, 2018, and 12,500 options will vest on each of December 18, 2019, 2020 and 2021.
- F3These stock options vest in four annual installments beginning on July 18, 2019, such that 3,916 options will vest on each of July 18, 2019, 2020 and 2021, and 3,915 options will vest on July 18, 2022.
- F4Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited.
- F5Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited.
Remarks
Exhibit List: Exhibit 24.1 - Power of Attorney